Sandor Victor — SEC Form 4 filings
SEC reporting owner CIK 1620368. 16 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-05-09 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 6,995 shares, $20,216 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 6,995 shares @ $2.89 ($20,216) in ADC Therapeutics SA, filed 2024-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ADC Therapeutics SA (ADCT) | Director | 5 | — | 1 leg · 6,995 sh · $20,216 | 5 |
| Merus N.V. (MRUS) | Director | 3 | — | — | 9 |
| Prelude Therapeutics Inc (PRLD) | Director | 4 | — | — | 4 |
| Kymera Therapeutics, Inc. (KYMR) | Director | 3 | — | — | 3 |
| AbCellera Biologics Inc. (ABCL) | Director | 1 | — | — | 1 |
Form 4 filings — Sandor Victor
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 152,207 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | ADC Therapeutics SA (ADCT) | Grant/award (A): 45,000 @ $0 · Tax withholding (F): 12,600 @ $3.08 | EDGAR |
| 2025-12-12 | 4 | Merus N.V. (MRUS) | Disposition to issuer (D): 13,193 (derivative) @ $0 · Disposition to issuer (D): 8,844 (derivative) @ $0 · Disposition to issuer (D): 14,414 (derivative) @ $0 · Disposition to issuer (D): 16,604 (derivative) @ $0 · Disposition to issuer (D): 6,120 (derivative) @ $0 · Disposition to issuer (D): 8,631 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-07 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 121,285 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | ADC Therapeutics SA (ADCT) | Tax withholding (F): 12,600 @ $3.58 | EDGAR |
| 2025-06-13 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | ADC Therapeutics SA (ADCT) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-05-27 | 4 | Merus N.V. (MRUS) | Grant/award (A): 13,193 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Prelude Therapeutics Inc (PRLD) | Grant/award (A): 23,500 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | ADC Therapeutics SA (ADCT) | Sale (S): 6,995 @ $2.89 | EDGAR |
| 2024-06-14 | 4 | ADC Therapeutics SA (ADCT) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-05-09 | 4 | Merus N.V. (MRUS) | Grant/award (A): 8,844 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1620368 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →